US Edition
Benchmark Holdings to delist following £260 million sale of Genetics arm
Summary by SalmonBusiness
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Benchmark Holdings to delist following £260 million sale of Genetics arm
Benchmark Holdings to delist following sale of Genetics arm to Novo Holdings Benchmark Holdings announced plans on Friday to delist from both AIM in London and Euronext Growth in Oslo, citing low liquidity and the high cost of maintaining public listings relative to its remaining operations. The decision follows the recent £260 million sale of [...]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
